Tags

Type your tag names separated by a space and hit enter

[New indications of ivermectin].
Rev Med Interne. 2001 Apr; 22(4):379-84.RM

Abstract

INTRODUCTION

Ivermectin is a semi-synthetic derivative of a family of macrocyclic lactones. This drug has a broad-spectrum anti-parasitic effect against various nematodes and ectoparasites. CURRENT KNOWLEDGE AND KEY-POINTS: Onchocerciasis and lymphatic filariasis are common indications. More recently ivermectin has been recommended in the treatment of strongyloidiasis and scabies.

FUTURE PROSPECTS AND PROJECTS

Promising results have been shown in the treatment of ascariasis, cutaneous larva migrans, loiasis and head lice.

Authors+Show Affiliations

Département des maladies infectieuses, tropicales et de parasitologie-mycologie, hôpital de la Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75651 Paris, France.No affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

fre

PubMed ID

11586522

Citation

Caumes, E, and M Danis. "[New Indications of Ivermectin]." La Revue De Medecine Interne, vol. 22, no. 4, 2001, pp. 379-84.
Caumes E, Danis M. [New indications of ivermectin]. Rev Med Interne. 2001;22(4):379-84.
Caumes, E., & Danis, M. (2001). [New indications of ivermectin]. La Revue De Medecine Interne, 22(4), 379-84.
Caumes E, Danis M. [New Indications of Ivermectin]. Rev Med Interne. 2001;22(4):379-84. PubMed PMID: 11586522.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [New indications of ivermectin]. AU - Caumes,E, AU - Danis,M, PY - 2001/10/6/pubmed PY - 2002/5/3/medline PY - 2001/10/6/entrez SP - 379 EP - 84 JF - La Revue de medecine interne JO - Rev Med Interne VL - 22 IS - 4 N2 - INTRODUCTION: Ivermectin is a semi-synthetic derivative of a family of macrocyclic lactones. This drug has a broad-spectrum anti-parasitic effect against various nematodes and ectoparasites. CURRENT KNOWLEDGE AND KEY-POINTS: Onchocerciasis and lymphatic filariasis are common indications. More recently ivermectin has been recommended in the treatment of strongyloidiasis and scabies. FUTURE PROSPECTS AND PROJECTS: Promising results have been shown in the treatment of ascariasis, cutaneous larva migrans, loiasis and head lice. SN - 0248-8663 UR - https://brain.unboundmedicine.com/medline/citation/11586522/[New_indications_of_ivermectin]_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0248-8663(01)00350-2 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.